Stay updated on Subcutaneous CDX-0159 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.

Latest updates to the Subcutaneous CDX-0159 Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for the Phase 1 CDX-0159 study is now displayed, including its eligibility criteria, study design, interventions, outcomes, and Nebraska location. The record indicates the study is completed and no longer recruiting.SummaryDifference38%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study record content; the error page and site chrome replace the typical study details, indicating the content is temporarily unavailable.SummaryDifference16%

- Check59 days agoChange DetectedThe page now shows Revision: v3.7.0, a minor version update that replaces the previous v3.6.6 revision.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous CDX-0159 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.